Commentary on: ``Improving the performance of Bayesian logistic regression model with overdose control in oncology dose-finding studies

DOI10.1002/SIM.9496zbMATH Open1547.62542MaRDI QIDQ6629386FDOQ6629386

Authors: Ying Yuan, Yixuan Zhao 

Publication date: 30 October 2024

Published in: Statistics in Medicine (Search for Journal in Brave)

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
• Bayesian optimal interval designs for phase I clinical trials
• A utility-based Bayesian optimal interval (U-BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies
• gBOIN: a unified model-assisted phase I trial design accounting for toxicity grades, and binary or continuous end points

This page was built for publication: Commentary on: ``Improving the performance of Bayesian logistic regression model with overdose control in oncology dose-finding studies

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6629386)